Screening, execution, and risk control — run on the Leaci Capital Scanner, Trader platform, built in-house.
At Leaci Capital, we specialize in catalyst-driven equity trading. We capitalize on market inefficiencies arising from biotechnology and pharmaceutical clinical trials, NASDAQ compliance events, macroeconomic shifts, and news-driven catalysts through strategic long and short positions. Our investment approach integrates fundamental research, statistical analysis, and technical indicators to execute across U.S. equity markets.
Positioning around FDA trial readouts and regulatory decisions, where binary outcomes create sharp mispricings.
Trading deficiency notices, reverse splits, and delisting risk before the market fully prices them in.
Adjusting exposure around CPI releases, rate decisions, economic data, and sector-wide moves.
Reacting quickly to breaking news, earnings surprises, and current events as they hit the tape.
Institutional trading at Leaci LLC runs on the Leaci Capital Scanner, Trader — our proprietary platform for screening, entry, and exit across both short and long positions.
Live candidate scanning across both sides of the market — short squeeze setups and established or penny-stock long candidates, side by side.
Swing highs and lows, pivot points, and volume profile merged into a single confluence score, so every level shown carries real weight.
From alert to fill: select a share size, borrow, and execute — a disciplined path from candidate to position.
Every position is sized and managed within strict risk parameters, prioritizing capital preservation alongside long-term growth.
Our proprietary screening tool — short and long candidates, support/resistance levels, and live alerts, watching the market so we don't have to blink.
Connect with Leaci LLC today. Discover how our unparalleled expertise can drive your financial success and meet your specialized service needs with sophistication and precision.
Get In Touch